Skip to content

Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03395665
Enrollment
299
Registered
2018-01-10
Start date
2014-01-31
Completion date
2018-01-31
Last updated
2018-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Miscarriage, Preimplantation Genetic Diagnosis/Screening

Brief summary

The development and improvement in Preimplantation genetic diagnosis/screening (PGS) in association with the efficacy and security of vitrification and trophectoderm biopsy, more efficient stimulation schemes and laboratory improvements in culture and embryo selection have contributed to high success of the assisted reproductive technologies(ART). Transferring an euploid embryo avoids one of the main reasons of miscarriage and implantation failure ( Rubio et al, 22016) and overcomes one of the most important confounding factors. Usually, the transfer of euploid embryos is performed under standard hormone replacement therapy (HRT) and are referred to as FET-PGS cycles( Frozen embryo transfer). The study of FET-PGS cycles with the transfer of a single euploid blastocyst is the best model for evaluation of the impact of the endometrial preparation . Among factors influencing FET outcomes, patient's age, endometrial preparation, endometrium thickness, endometrial pattern, number and quality of embryos transferred , difficulty at ET, recently P4 have received more attention . The importance of Progesterone (P4) in embryo implantation has been widely studied. P4 plays an important role in endometrial gland formation, embryonic implantation and pregnancy maintenance, both in natural and artificial cycles.

Interventions

Estradiol level measured at previous day of embryo transfer procedure

OTHERProgesterone level

Progesterone level measured at previous day of embryo transfer procedure

OTHEREndometrial thickness

Endometrial thickness measured at previous day of embryo transfer procedure

Sponsors

Fundacion Dexeus
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years

Inclusion criteria

* Frozen embryo transfer (FET) of at least one single euploid embryo. * Estradiol \> 75pg/ml. * Progesterone \> 4 ng/ml. * Endometrial thickness between 6 mm and 18 mm.

Exclusion criteria

* Patients with FET of no diagnostic or mosaic embryos, or known uterine abnormality were excluded. * Natura cycle protocol.

Design outcomes

Primary

MeasureTime frameDescription
Live birth rateTen months after transfer procedure
Miscarriage rateAny pregnancy loss before week 20Miscarriage was defined as a loss following a positive pregnancy test and/or detectable Gestational sac
Pregnancy rate6 weeks after transfer procedure

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026